Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews

Like the Progress Educational Trust on Facebook


 


 

New guidelines drawn up in fight against rogue stem cell clinics

08 December 2008

By Ben Jones

Appeared in BioNews 487

The International Society for Stem Cell Research (ISSCR) has this week warned patients against unproven stem cell treatments being offered by rogue clinicians. The calls were made to governments to tighten their regulatory regimes to crack down on those exploiting the vulnerable with claims of revolutionary stem cell-based treatments that are not substantiated by peer reviewed publications and that carry significant potential for harm.

The ISSCR organised a task force of thirty academics and clinicians from thirteen countries to produce the guidelines, which they claim have been formulated with the participation of 'key international stakeholders' in stem cell research and development. Insoo Hyun, associate professor of bioethics at Case Western Reserve University School of Medicine in Cleveland, US, the lead author of a paper in the journal Cell: Stem Cell, introduced the guidelines. He told the Washington Post that: 'legitimate science is speeding ahead and getting to the point where there needed to be more of a road map to take the basic knowledge to clinical applications' - the problem in the short term being those attempting to profit from the hope generated by these rapid successes.

The proliferation of adverts online for dubious clinics offering ambiguous stem cell therapies at prices rising to the tens of thousands of pounds were taken as evidence that there is an urgent need for international standards to be drawn up. Specifically targeted are the minimally regulated regimes in Central and South America, the Far East and India where most of these adverts lead. George Daley, of the Boston Children's Hospital, and one of the contributors to the guidelines, told the Times: 'I think these websites are dangerous. They overpromise effectiveness and safety of the therapy and under inform about risks. Overhyped marketing direct to patients is putting patients at risk of financial exploitation at the very least, and physical danger at the worst.'

Alongside the guidelines, aimed at governmental regulators, a patient information booklet was also released containing questions that patients should pose to clinicians when being offered novel or experimental therapies and warning them against clinics claiming to treat multiple conditions with a single therapy. (The guide is available to download at http://tinyurl.com/ISSCR.) The guidelines note that though there is sometimes a place for unproven treatments to be used outside of a clinical trial, that these occasions are rare.

However one of the co-chairs of the task force, Olle Lindvall, Professor of Neurology at Lund University, Sweden, has already expressed concerns that the guidelines may have little effect on those clinics operating outside of the scientific mainstream. In an interview with Nature he noted that 'more of the clinics are interested in making money than in helping patients' and that it was simply hoped that the formation of international consensus might lead countries to crack down on rogue practitioners.

SOURCES & REFERENCES
The Washington Post | 03 December 2008
 
Internet stem-cell clinics 'exploiting' MS and Parkinson's patients
The Times | 03 December 2008
 
New Scientist | 03 December 2008
 
Nature | 03 December 2008
 

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

10 November 2008 - by Stuart Scott 
Functioning brain tissue has been produced from stem cells, in a world first experiment, offering insights into a number of neurodegenerative disorders and, ultimately, the possibility of improved treatments. Japanese researchers, based at the government funded research institute Riken in Kobe induced human embryonic stem (ES) cells...
27 October 2008 - by Dr Charlotte Maden 
The California Institute for Regenerative Medicine (CIRM) and the UK's Medical Research Council (MRC) have signed an agreement that supports collaborations between the two countries. Teams of scientists from the UK and California will now be able to file joint grant applications for funding into stem cell...
29 September 2008 - by MacKenna Roberts 
Both candidates in the race for the US presidency - Republican John McCain and Democrat Barack Obama - have released misleading stem cell policy radio advertisements. Although both campaign ads were technically true, Obama misrepresented McCain's current views in support of the research and McCain misrepresented the opposition of...
22 September 2008 - by Ben Jones 
The Japanese Patent Office has granted the first patent for induced pluripotent stem cells (iPS cells) to Kyoto University, where researcher Shinya Yamanaka produced both the first non-human iPS cells in 2006 and, using the same process, the first human iPS cells in 2007.The Japanese patent...

HAVE YOUR SAY
Be the first to have your say.

You need to or  to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions


- click here to enquire about using this story.

Published by the Progress Educational Trust

CROSSING FRONTIERS

Public Conference
London
8 December 2017

Speakers include

Professor Azim Surani

Professor Magdalena Zernicka-Goetz

Professor Robin Lovell-Badge

Sally Cheshire

Professor Guido Pennings

Katherine Littler

Professor Allan Pacey

Dr Sue Avery

Professor Richard Anderson

Dr Elizabeth Garner

Dr Andy Greenfield

Dr Anna Smajdor

Dr Henry Malter

Vivienne Parry

Dr Helen O'Neill

Dr César Palacios-González

Philippa Taylor

Fiona Fox

Sarah Norcross

Sandy Starr


BOOK HERE

Good Fundraising Code

Become a Friend of PET HERE and give the Progress Educational Trust a regular donation